FDA Inspection 921908 — Orient Pharma Co., Ltd.

Orient Pharma Co., Ltd. — FEI 3009057557

The FDA completed an inspection of Orient Pharma Co., Ltd. on Apr 3, 2015 in Yunlin County. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 3, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yunlin County (Taiwan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.